Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-6ktzzh8Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial comparing Morphine, Methadone and Placebo (3 arms). Primary endpoint: Short-term affective effects after pre-anesthetic opioid administration. Planned start Aug 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-6ktzzh8.